Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Agenus Inc (AGEN)

Agenus Inc (AGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,356,729
  • Shares Outstanding, K 233,115
  • Annual Sales, $ 88,170 K
  • Annual Income, $ -180,910 K
  • 60-Month Beta 1.35
  • Price/Sales 15.41
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AGEN with:

Options Overview

Details
  • Implied Volatility 77.47%
  • Historical Volatility 67.52%
  • IV Percentile 12%
  • IV Rank 8.66%
  • IV High 181.57% on 02/04/21
  • IV Low 67.60% on 08/09/21
  • Put/Call Vol Ratio 0.02
  • Today's Volume 7,218
  • Volume Avg (30-Day) 4,592
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 70,226
  • Open Int (30-Day) 79,803

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.46
  • Number of Estimates 3
  • High Estimate 0.57
  • Low Estimate 0.28
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +264.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.33 +9.19%
on 09/16/21
6.79 -14.29%
on 08/30/21
-0.23 (-3.80%)
since 08/20/21
3-Month
4.75 +22.53%
on 07/27/21
6.79 -14.29%
on 08/30/21
+0.56 (+10.65%)
since 06/18/21
52-Week
2.50 +132.80%
on 04/20/21
6.79 -14.29%
on 08/30/21
+0.64 (+12.36%)
since 09/18/20

Most Recent Stories

More News
Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer in Data to Be Presented at ESMO

-- Objective response rate of 33% and median duration of response not reached with 19.4 months median follow-up in PD-L1+ tumors; expands benefit of anti-PD-1 alone

AGEN : 5.82 (-0.17%)
New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks

Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections...

AGEN : 5.82 (-0.17%)
SRNG : 11.42 (+12.73%)
Agenus to Participate in September Investor Conferences

Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections,...

AGEN : 5.82 (-0.17%)
Balstilimab Monotherapy Data Published in Gynecologic Oncology

-- Objective response rate of 20% and median duration of response not reached with 14.6 month median follow-up in PD-L1+ tumors

AGEN : 5.82 (-0.17%)
Agenus (AGEN) Reports Q2 Loss, Misses Revenue Estimates

Agenus (AGEN) delivered earnings and revenue surprises of -54.17% and -36.75%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

AGEN : 5.82 (-0.17%)
The Surge in New Cases Reinforces the Importance of a Healthy Lifestyle

/PRNewswire/ -- While most of the economy has reopened, the number of new cases is once again on the rise. This time, two variants of COVID-19, the delta and lambda variants, are causing the numbers of...

TOMDF : 0.0420 (unch)
AGEN : 5.82 (-0.17%)
HOLX : 76.73 (-1.16%)
VBIV : 3.15 (-4.83%)
IBIO : 1.1400 (-7.32%)
Agenus: Q2 Earnings Snapshot

LEXINGTON, Mass. (AP) _ Agenus Inc. (AGEN) on Monday reported a loss of $84 million in its second quarter.

AGEN : 5.82 (-0.17%)
Agenus Corporate Update and Second Quarter 2021 Financial Report

-- FDA cleared IND for AGEN1777 clinical enrollment

AGEN : 5.82 (-0.17%)
Agenus to Participate in the BTIG Virtual Biotechnology Conference 2021

Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections,...

AGEN : 5.82 (-0.17%)
Will Agenus (AGEN) Report Negative Earnings Next Week? What You Should Know

Agenus (AGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AGEN : 5.82 (-0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's...

See More

Key Turning Points

3rd Resistance Point 6.38
2nd Resistance Point 6.18
1st Resistance Point 6.00
Last Price 5.82
1st Support Level 5.62
2nd Support Level 5.42
3rd Support Level 5.24

See More

52-Week High 6.79
Last Price 5.82
Fibonacci 61.8% 5.15
Fibonacci 50% 4.64
Fibonacci 38.2% 4.14
52-Week Low 2.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar